Weinand is the former CEO and Chairman of the Board at Bayer Pharma AG, leading Bayer’s fully integrated $20 billion healthcare business
JDHL has a strong reputation as an end-to-end design-focused manufacturer of electro-medical devices
The company through its IPO will fetch Rs 1475.26 crore - Rs 1550.59 crore at the lower and upper end of the price band.
Advances clinical research capabilities with leading regulatory grade registries platform
The launch of HULIO in the United States is an important milestone for Biocon Biologics
The drug discovery of mRNA-targeted small molecules is rapidly gaining attention due to the current difficulty of developing drugs against conventional protein targets
‘Fibrotic disease’ is a term that covers a range of diseases characterized by uncontrolled and progressive fibrosis,
Proposed divestiture of BioPharma Solutions (BPS) further streamlines Baxter’s strategic focus and represents an important milestone in its ongoing business transformation
The acquisition of Medisol is part of Lupin's strategy to expand its presence in the EU
The news on a shift in its focus comes after the refinement of Bayer’s early innovation framework
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
